siRNA- or shRNA-mediated gene knockdown screenings and CRISPR-mediated gene knockout screenings, coupled to next-generation sequencing, have been broadly used for identification of mechanisms of cancer resistance to several protein kinase inhibitors and, as a result, of new targetable vulnerabilities [90,91]. Here, WEE1 is linked to cancer.